Beata Bode‐Lesniewska
Papers
1
Total Citations
28
H-Index
1
About
Dr. Beata Bode-Lesniewska is a leading pathologist whose research focuses on the molecular characterization of rare soft tissue and bone tumors, with a particular emphasis on sarcomas and inflammatory myofibroblastic tumors (IMTs). Her major contributions lie in elucidating the genetic drivers of these neoplasms, especially ALK gene rearrangements, and translating these findings into targeted therapeutic strategies. Her highly cited 2020 study on an IMT of the bladder with a rare FN1-ALK gene fusion demonstrated a differential response to ALK inhibition, showing that while crizotinib failed to induce regression, it highlights the critical need for genotype-matched therapies in rare, unresectable tumors. This work, with 28 citations, underscores her impact on precision oncology for orphan diseases. Dr. Bode-Lesniewska’s expertise in integrating histopathology with molecular diagnostics has advanced the understanding of tumor biology and guided clinical decision-making, making her a pivotal figure in sarcoma research and a valuable resource for clinicians and scientists tackling diagnostically challenging malignancies.
Research Focus
Key Achievements
Top Papers
- 1